Skip to content
Boca Raton City Online – Lifestyle
Author:
Sapreme Therapeutics
Sapreme Therapeutics announces oral presentation of new preclinical data on lead Duchenne muscular dystrophy candidate SPM-2551 at OTS 2026
October 14, 2026